- |||||||||| ivermectin oral / Generic mfg.
ILEAL ENDOCRINE TUMOR WITHOUT METASTASIS. (Babcock #6 (Sunset Center)) - Dec 20, 2021 - Abstract #WSMRF2022WSMRF_320; Right hemicolectomy with small bowel mass was resected, surgical pathology reported well differentiated neuroendocrine tumor, forming multiple (13) mucosal masses extending up to 2.3 cm with focal angiolymphatic invasion and 3/18 regional lymph nodes involvement. After this, diarrhea improved, and patient followed up with a medical oncologist.
- |||||||||| hydroxychloroquine / Generic mfg., ivermectin oral / Generic mfg.
Journal: Potential Drugs for the Treatment of COVID-19: Synthesis, Brief History and Application. (Pubmed Central) - Dec 16, 2021 Scientists around the world are investigating few previously used clinical drugs for the treatment of COVID-19. This review provides synthesis and mode of action of recently investigated drugs like Chloroquine, Hydroxychloroquine, Ivermectin, Selamectin, Remdesivir, Baricitinib, Darunavir, Favipiravir, Lopinavir/ritonavir and Mefloquine hydrochloride that constitute an option for COVID-19 treatment.
- |||||||||| ivermectin oral / Generic mfg.
Clinical, Review, Journal: Scabies in remote Aboriginal and Torres Strait Islander populations in Australia: A narrative review. (Pubmed Central) - Dec 16, 2021 This article is a narrative review of scabies in remote Aboriginal and Torres Strait Islander populations in Australia, including clinical manifestations of disease and current treatment options and guidelines. We discuss traditional approaches to prevention and control as well as suggestions for future interventions including revising Australian treatment guidelines to widen the use of oral ivermectin in high-risk groups or as a first-line treatment.
- |||||||||| ivermectin oral / Generic mfg.
Journal: Ivermectin: 21st Century "Snake Oil" or Safe and Effective for COVID-19? (Pubmed Central) - Dec 16, 2021 We discuss traditional approaches to prevention and control as well as suggestions for future interventions including revising Australian treatment guidelines to widen the use of oral ivermectin in high-risk groups or as a first-line treatment. No abstract available
|